Breathalyzer Market, SpinDetect™ Launch, and Business Outview – Minichart

Lifeloc Technologies, Inc. Annual Report Analysis for Investors

Overview of the Annual Report

Lifeloc Technologies, Inc. has released its Annual Report for the fiscal year finished December 31, 2025. The company remains listed on the OTC Markets Group, Inc., with trading in its common stock described as limited and sporadic. As of December 31, 2025, Lifeloc had 65 shareholders of record, with the common stock not listed on a national securities exmodify.

Financial Performance Highlights

Revenue Growth: Revenues increased from \$5,066,779 in 2024 to \$5,375,787 in 2025, representing a 6% growth. Gross profit margin remained steady at 40% for both years, suggesting stable pricing and cost management.
Research, Development, and Sustaining Engineering: Expenses were largely unmodifyd, totaling \$1,331,062 in 2025 versus \$1,358,211 in 2024, indicating ongoing commitment to innovation without significant cost escalation.
General and Administrative Expenses: These rose by 11% to \$1,388,160 in 2025, largely due to increased public company and legal expenses related to S-4 filings.
Interest Income & Expense: Interest income decreased slightly to \$38,010 while interest expense jumped to \$119,190 from \$40,145, reflecting the impact of new debt issuance and amortization costs.
Net Loss: The company reported a net loss of \$2,470,399 for the year, signaling ongoing challenges in achieving profitability.

Capital Structure and Recent Transactions

Stock Issuance: In July 2024, Lifeloc completed a private placement of 210,000 shares at \$3.80 per share, raising \$798,000 with a related party.
Debenture Issuances: On December 31, 2024, the company issued a six-year unsecured subordinated debenture for \$750,000. On March 1, 2025, it issued a 70-month unsecured subordinated debenture for \$75,000. Both are at 8.25% per annum.
Warrants: Warrants to purchase 62,500 shares at \$4.50 (valued at \$120,000) and 6,250 shares at \$4.50 (valued at \$12,000) were issued, exempt from registration as private placements.
Option Exercises: Option exercises in February 2025 raised \$336,300 for general corporate purposes and working capital.
Outstanding Shares: As of March 25, 2026, there were 1,752,616 shares of common stock outstanding.

Strategic Focus and Product Development

SpinDetect™ Launch: The company is focutilized on launching SpinDetect™ in 2026, with expectations of modest revenue improvements. This product is seen as a key driver for future growth and profitability.
R&D and Innovation Risks: The report highlights the importance of innovation, noting risks associated with failing to predict customer requireds, allocate R&D funding wisely, and commercialize new technologies in a timely manner. Investments in new products are inherently risky and may disrupt ongoing business.

Risk Factors and Shareholder Considerations

Key Personnel Risk: The business is highly depfinishent on CEO & President Dr. Wayne R. Willkomm. Loss of his services could severely damage the company.
Labor Shortages: Intense competition for scientific and technical talent poses a risk. Failure to attract and retain key employees could hinder product innovation and business growth.
Debt Service and Financial Flexibility: The company’s outstanding debt (over \$825,000 in subordinated debentures plus a corporate mortgage) requires ongoing service. If revenues decline or operating costs rise, Lifeloc may face challenges in meeting obligations, potentially requiring asset sales or unfavorable financings.
Quarterly Fluctuations: Revenues and profits are expected to continue fluctuating quarter-to-quarter due to unpredictable timing and size of customer orders, regulatory modifys, and competitive pressures.
Market and Economic Uncertainty: Global economic instability, inflation, and supply chain disruptions could negatively impact revenues and profitability.
Cybersecurity and Data Privacy: Increasingly common regulations may impact product utilize and market; breaches could lead to legal liability, financial losses, and negative publicity.
Climate Change: Ongoing climate modify may increase costs or reduce demand for products, requiring additional resources for emissions management.
Share Liquidity: Shares are illiquid, traded OTC, and subject to significant volatility. There is no assurance of an active trading market, which may depress share prices.
Principal Shareholder Influence: Mr. Kornelsen holds a significant ownership interest, enabling him to influence major corporate decisions, including mergers, asset sales, and modifys to bylaws. This may affect corporate governance perceptions and risk profile.
No Dividfinishs: The company has never declared or paid cash dividfinishs and intfinishs to retain earnings for operations and expansion. Investors should not anticipate dividfinishs in the foreseeable future.
Future Dilution: Issuance of options and warrants to employees, consultants, and directors, or for capital raising, will further dilute existing shareholder interests.
Blue Sky Laws: State law restrictions may limit the ability of investors to resell securities, and the secondary market is expected to be limited.
Compliance Costs: Evolving regulations (e.g., Sarbanes-Oxley, SEC) increase administrative expenses and management distraction from revenue-generating activities.

Audit Report and Critical Accounting Policies

Unqualified Opinion: The indepfinishent auditor, Assure CPA, LLC, provided an unqualified opinion on the financial statements for 2025 and 2024, confirming compliance with GAAP and noting no critical audit matters.
Estimates and Judgments: The financial statements rely on management’s estimates and assumptions regarding assets, liabilities, revenues, and expenses. Changes in these estimates could affect reported results.
Inventory Write-downs: The company reduces inventory for obsolescence based on projected demand and market conditions. Additional write-downs may be required if actual conditions worsen.
No Off-balance Sheet Arrangements: The company has no off-balance sheet arrangements that could materially affect its financial condition.

Conclusion

Lifeloc Technologies, Inc. faces both opportunities and risks in 2026. The anticipated launch of SpinDetect™ and expanded sales efforts could drive growth, but persistent net losses, increased debt obligations, and operational risks (including personnel, compliance, and cybersecurity) remain substantial. Investors should closely monitor developments, especially regarding product launches, capital structure, and regulatory modifys, as these may materially affect share values. The illiquid nature of the stock, significant principal shareholder influence, and lack of dividfinishs are also key considerations for current and prospective shareholders.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial advisors before building investment decisions. The information is based on the company’s annual report for the period finishing December 31, 2025 and may not reflect subsequent events or modifys. Lifeloc Technologies, Inc. is subject to risks including operational, financial, regulatory, and market risks as described herein.